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A 24-year-old man presented himself with a nodular lesion of about 1cm diameter at the site of a previous orchiopexy associated
with surgery for cryptorchism. Histopathology revealed the lesion to be adenomatous and conﬁned to the scrotum. Histological
and immunohistological features were not consistent neither with median raphe cysts or cutaneous adenomas nor with the
intrascrotal adenomas of the rete testis, epididymis, nor with (malignant) mesotheliomas. However, the lesion did compare
well with serous (papillary) cystadenomas of the testis or paratestis. These adenomas are thought to originate in remnants of
the M¨ ullerian system or of peritoneal lining altered by M¨ ullerian metaplasia. This implies that the scrotal adenoma may have
developed from an implant of such elements during orchiopexy 14 years ago. Complete excision of the lesion appears to be an
adequate therapy.
Copyright © 2009 Sebastian C. J. van der Putte et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Tumors and tumor-like lesions in the scrotum comprise a
wide spectrum of conditions related to the scrotum and
to the testis and paratestis [1, 2]. These two categories of
“scrotal” and “intrascrotal” lesions are strictly separated by
the anatomical barrier of the tunica vaginalis.
In 2004, Hara et al. [3] described an adenomatous
tumor which appeared to have developed at the site of an
orchiopexy performed two weeks earlier and involved the
scrotum as well as the testis. They diagnosed the lesion as
a median raphe cyst with features of a borderline serous
cystadenoma. In 2007, Dehner et al. [4]r e p o r t e dap a t i e n t
with a similar condition who had been operated on seven
years earlier and classiﬁed the lesion as a median raphe cyst.
We present a third case which oﬀered an extra diagnostic
challengebyabsenceofinvolvementofthetestisorparatestis.
On the basis of histopathological criteria, we dismiss the
diagnosis of median raphe cyst and classify the disorder as
a serous cystadenoma originating in a M¨ ullerian implant in
the scrotum.
2. Case Presentation
A 24-year-old male noticed a circumscribed swelling in the
skin of his left scrotum. Physical examination showed a
1.5cm nodus at the site of an orchiopexy performed for
cryptorchism 14 years earlier. It was excised under local
anesthesia under the suspected diagnosis of pilar cyst. No
connection with intrascrotal structures was noticed.
Macroscopyshowedanellipsoid2.5×1.5×1cmspecimen
with a ﬁrm 1cm tumor. Microscopic sections revealed an
irregular tubulocystic epithelial proliferation surrounded by
a mantle of connective tissue and embedded in the smooth
musculature of the dartos fascia (Figure 1(a)). The tumor
wascompletelyremovedwithaverynarrowfreemargin.The
tubulocystic element spread outward from a central sinus
thatopenedexternallyatthesurfaceoftheskinandwaslined
byacornifyingstratiﬁedsquamousepithelium(Figure 1(a)).
Metaplastic noncornifying stratiﬁed squamous epithelium
in the deepest part of the sinus passed into columnar to
cuboidal epithelium in the tubulocystic component of the






















Figure 1: Histological and immunohistochemical features of the scrotal serous cystadenoma at the side of an orchiopexy 14 years earlier.
(a) Low magniﬁcation shows a tubulocystic tumor (between large arrowheads) surrounded by connective tissue and embedded in the
dartos fascia (asterisks). Note its connection to the epidermis by a sinus (1) lined by cornifying stratiﬁed squamous epithelium and
opening at the surface (arrow). (b) Detail of metaplastic noncornifying stratiﬁed squamous epithelium (2) passing into a single-layered
columnar epithelium of the tubulocystic system (3) in the deepest part of the sinus. (c) Cystic papillary component. (d) Detail of a ﬁbrous
papilla covered by characteristic tall columnar epithelium with ciliated cells (small arrowheads). (e) Cytological and immunohistochemical
characteristics discriminating the tumor from other scrotal and intrascrotal lesions. Vim: Vimentin; ER: Estrogen receptor; PR: Progesterone
receptor; Calret: Calretinin; SMA: Smooth muscle actin.
slit-likeandpapillaryconﬁgurationswerealsoobserved(Fig-
ures1(c),1(d)).Variablenumbersofcellsshowedprominent
apical snouts or cilia (Figures 1(d), 1(e)). The epithelium
was bland, mitotic ﬁgures were rare, and microinvasion was
absent. Psammona bodies were not observed.
A specially selected diﬀerential diagnostic panel of
immunohistochemical tests demonstrated reactivity for
cytokeratin (CK) 7 (Biogenex, San Ramon, USA), vimentin
(DAKO, Glastrup, Denmark), Ca-25 (Novocastra, Newcas-
tle, UK), estrogen receptor (ER), progesterone receptorAdvances in Urology 3
(PR) (DAKO), nonreactivity for CK 20 (DAKO), calretinin
(Klinipath, Duiven, The Netherlands), and alpha-smooth
muscle actin (SMA) (Sigma, St Louis, USA). This proﬁle was
inconsistent with scrotal median raphe cysts (nonreactive
for vimentin) (three cases tested) and cutaneous papillary
hidradenomas (reactive for SMA in myoepithelium) (three
cases tested). With respect to the possibility of a deriva-
tion from paratesticular structures (three cases tested), the
immunoproﬁle of the tumor did not match those of the rete
testis and mesothelium (nonreactive for Ca-125, ER, and
PR, but reactive for calretinin) or epididymis (nonreactive
for Ca-125 and variably reactive for vimentin, ER, and
PR). However, in concordance with cytological details, the
proﬁle of the tumor is similar to that of serous (papillary)
cystadenoma of the ovary (three cases tested). The MIB1 cell
proliferation index was 1.5%.
3. Discussion
The present case appears to be almost identical in clin-
ical and histopathological aspects to those described by
Hara et al. [3]a n dD e h n e re ta l .[ 4]. It diﬀered in the longer
interval between the orchiopexy and the manifestation of
the anomaly and its conﬁnement to the scrotum. Their
argumentation, in favor of a classiﬁcation of the lesion as a
median raphe cyst though, was not convincing.
Median raphe cysts are localized in the midline between
the preanal perineum and the external urinary meatus
and typically show a urethra type of epithelium which
is pseudostratiﬁed columnar epithelium with occasional
mucus production or cilia and often undergoes squamous
metaplasia [5–8] (own unpublished observations in 19
cases). Cysts near the meatus predominate and can be
explained by a derivation from ectopic urethral glands [9].
Cysts (and canals) related to the rest of the raphe, which
is at some distance from the urethra and its glands, are
thought to have grown from the embryonic urogenital sinus
epithelium which had remained in the raphe after it had
been formed by fusion of the urethral folds during the
formation of the phallic urethra [5, 7, 8]. This theory has
to be dismissed as it has recently been established that such
fusion does not take place [10]. However, the idea that
raphe cysts derive from urogenital sinus epithelium can be
upheld as the same study also revealed that this epithelium
temporarily lines the cloacal groove which derives from
the middle segment of the cloaca between the urogenital
and anal compartments of the cloaca and at the surface
of the perineum elongates into the male raphe later. Both
the urethra type of epithelium and the direct relation-
ship with the raphe are lacking in the lesions described
by Hara et al. [3]a n dD e h n e r e t a l .[ 4] and also in our
case.
The possibility that the lesion had developed from
cutaneousglandshadtobediscardedaswell.Suchadenomas
characteristically show a basal layer of smooth muscle actin-
positive myoepithelium [11] which was missing in our case.
The absence of a primarily scrotal alternative diagnosis,
the localization at the site of the orchiopexy, and the
involvement of the paratestis as reported by Hara et al. [3]
and Dehner et al. [4] suggest a paratesticular derivation.
Among the adenomatous tumors in this category, the adeno-
matoid tumor [1, 12, 13] and papillary cystadenoma of the
epididymis [1, 12–14] have a distinctly diﬀerent morphology
and a diﬀerent immunoproﬁle. The cystadenoma of the rete
testis and (malignant) mesothelioma may have a certain
morphological resemblance but diﬀer in immunoproﬁle
especially by showing reactivity for calretinin [12].
The histological and immunohistochemical features of
the lesion were indeed well in accordance with those of the
serous(papillary)cystadenomasoftheparatestis(andovary)
[12, 13, 15] as discovered by Hara et al. [3]. These serous
cystadenomas are rare tumors which become manifest as
a painless swelling in mostly middle-aged men and appear
to be similar to their ovarian counterparts. Mild atypia in
combination with stratiﬁcation may lead to the suspicion of
borderline malignancy but prognosis after complete removal
was excellent [13]. Mitotic activity was low.
These cystadenomas are thought to originate in rem-
nants of the M¨ ullerian (paramesonephric) system and/or
by M¨ ullerian metaplasia of the peritoneal lining of the
tunica vaginalis [1, 12]. In the present speciﬁc situation of
an isolated scrotal localization, this would mean that the
lesion is the result of implantation of M¨ ullerian tissue in
the incision for the orchiopexy. It is not clear if the external
opening in our patient and the drainage in the case of
Dehner et al. [4] are a primary or secondary event.
The precise nature of the tumor is still obscure. The
presumed development of the lesion of Hara et al. [3] within
two weeks after the operation appears highly unusual for
an adenoma. The report of three cases of this adenoma in
relation with orchiopexy as compared with the report of less
than 40 cases of testicular and paratesticular cystadenoma
in the general male population [12] is remarkable and
suggests some sort of special stimulus on the ectopic tissue.
The growth of the tumor over a twenty-one-month period
as observed by Hara et al. [3] demonstrates a progressive
character. Their grading of the lesion as a borderline
malignancy may be disputed because mild atypia in some
epithelial cells as the only indicator falls far short of
criteria currently applied to the ovarian counterpart [16].
The disease-free follow-up periods of at least 40 months
[3] and 14 months (our patient) suggest that, like the
testicular or paratesticular cystadenoma, complete excision
may be adequate but it is evident that more data are
needed.
4. Conclusions
Orchiopexy may be complicated by an adenomatous tumor
morphologicallyidenticaltotheM¨ ullerianserous(papillary)
cystadenoma of the paratestis. Conﬁnement of the present
lesion to the scrotum suggests implantation of M¨ ullerian
elements during the operation. The previous designation
“median raphe cyst mimicking a serous borderline tumor”
is incorrect. The still-limited data available suggest that
complete excision may be an adequate therapy.4 Advances in Urology
References
[1] T. M. Ulbright, M. B. Amin, and R. H. Young, “Miscellanous
primary tumors of the testis, adnexa and spermatic cord,
hematopoietic tumors and secondary tumors,” in Tumors of
t h eT e s t i s ,A d n e x a ,S p e r m a t i cC o r d ,a n dS c r o t u m ,A t l a so f
Tumor Pathology, 3rd Series, Fascicle 25, pp. 235–295, Armed
Forces Institute of Pathology, Washington, DC, USA, 1999.
[ 2 ] T .M .U l b r i g h t ,M .B .A m i n ,a n dR .H .Y o u n g ,“ T h es c r o t u m , ”
in Tumors of the Testis, Adnexa, Spermatic Cord, and Scrotum,
Atlas of Tumor Pathology, 3rd Series, Fascicle 25, pp. 343–373,
Armed Forces Institute of Pathology, Washington, DC, USA,
1999.
[3] N. Hara, M. Kawaguchi, H. Koike, and K. Takahashi, “Median
raphe cyst in the scrotum, mimicking a serous borderline
tumor, associated with cryptorchidism after orchiopecxy,”
InternationalJournalofUrology,vol.11,no.12,pp.1150–1152,
2004.
[4] L. P. Dehner, H. Yin, and R. Yost, “Median raphe cyst in the
scrotum after orchiopexy,” International Journal of Urology,
vol. 14, no. 6, pp. 573–574, 2007.
[5] J. S. Little Jr., M. A. Keating, and R. C. Rink, “Median raphe
cysts of the genitalia,” The Journal of Urology, vol. 148, no. 6,
pp. 1872–1873, 1992.
[6] P. H. McKee, E. Calonje, and S. R. Granter, “Diseases of
the genital skin,” in Pathology of the Skin With Clinical
Correlations, pp. 437–539, Elsevier Mosby, Philadelphia, Pa,
USA, 3rd edition, 2005.
[ 7 ]R .C a r d o z o ,J .D .F r e i t a s ,J .P .R e i s ,a n dO .T e l l e c h i a ,“ M e d i a n
raphe cyst of the penis,” Dermatology Online Journal, vol. 11,
no. 3, pp. 37–40, 2005.
[8] C. O. Park, E. Y. Chun, and J. H. Lee, “Median raphe cyst on
the scrotum and perineum,” Journal of the American Academy
of Dermatology, vol. 55, no. 5, supplement 1, pp. S114–S115,
2006.
[9] L. A. Cole and E. B. Helwig, “Mucoid cysts of the penile skin,”
The Journal of Urology, vol. 115, no. 4, pp. 397–400, 1976.
[10] S.C.J.vanderPutte,“Thedevelopmentoftheperineuminthe
human,”inAdvancesinAnatomy,Embryology andCellBiology,
vol. 177, Springer, Berlin, Germany, 2005.
[11] F. Eckert, M. Betke, C. Schmoeckel, J. Neuweiler, and U.
Schmid, “Myoepithelial diﬀerentiation in benign sweat gland
tumors: demonstrated by a monoclonal antibody to alpha-
smooth muscle actin,” Journal of Cutaneous Pathology, vol. 19,
no. 4, pp. 294–301, 1992.
[12] M. B. Amin, “Selected other problematic testicular and parat-
esticular lesions: rete testis neoplasms and pseudotumors,
mesothelial lesionsand secondary tumors,”Modern Pathology,
vol. 18, supplement 2, pp. S131–S145, 2005.
[ 1 3 ]R .F .M c C l u r e ,G .L .K e e n e y ,T .J .S e b o ,a n dJ .C .C h e v i l l e ,
“Serous borderline tumor of the paratestis: a report of seven
cases,” The American Journal of Surgical Pathology, vol. 25, no.
3, pp. 373–378, 2001.
[14] H. Aydin, R. H. Young, B. M. Ronnett, and J. I. Epstein, “Clear
cellpapillarycystadenomaoftheepididymisandmesosalpinx:
immunohistochemical diﬀerentiation from metastatic clear
cell renal cell carcinoma,” The American Journal of Surgical
Pathology, vol. 29, no. 4, pp. 520–523, 2005.
[15] K. S. Carano and R. A. Soslow, “Immunophenotypic analysis
of ovarian and testicular M¨ ullerian papillary serous tumors,”
Modern Pathology, vol. 10, no. 5, pp. 414–420, 1997.
[16] W. R. Hart, “Borderline epithelial tumors of the ovary,”
Modern Pathology, vol. 18, supplement 2, pp. S33–S50, 2005.